Clinical trial · Interventional
The Effect of Dexmedetomidine on Postoperative Analgesia
Assessment of the Effect of Dexmedetomidine in the Management of Postoperative Pain When Combined With Fentanyl in the Patient-controlled Analgesia
NCT01373021CI-TRIAL-00006415completedPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine whether additional Dexmedetomidine to patient controlled analgesia can reduce fentanyl consumption.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Cancer, Rectal Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.85 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Dexmedetomidine | Drug | — | UNRESOLVED |
| Fentanyl | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- PLACEBO_COMPARATOR
- label
- F
- description
- Fentanyl+Normal saline
- interventionNames
- Drug: Fentanyl
- type
- EXPERIMENTAL
- label
- D
- description
- Fentanyl+Dexmedetomidine
- interventionNames
- Drug: Dexmedetomidine
Primary outcomes (1)
- measure
- total amount of administered fentanyl
- timeFrame
- during first 24 hours after surgery
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 74 Years
Show eligibility criteria text
Inclusion Criteria: * Elective surgery for colon cancer Exclusion Criteria: * Liver disease * Kidney disease * Allergy for study drugs * Inability to receive patient controlled analgesia
References
Publications (0)
Data not yet available
No reference posted for this study.